Kancera AB (Sweden) Probability of Future Stock Price Finishing Over 2.07

KAN Stock  SEK 0.97  0.06  5.83%   
Kancera AB's future price is the expected price of Kancera AB instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kancera AB performance during a given time horizon utilizing its historical volatility. Check out Kancera AB Backtesting, Kancera AB Valuation, Kancera AB Correlation, Kancera AB Hype Analysis, Kancera AB Volatility, Kancera AB History as well as Kancera AB Performance.
  
Please specify Kancera AB's target price for which you would like Kancera AB odds to be computed.

Kancera AB Target Price Odds to finish over 2.07

The tendency of Kancera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over kr 2.07  or more in 90 days
 0.97 90 days 2.07 
about 21.76
Based on a normal probability distribution, the odds of Kancera AB to move over kr 2.07  or more in 90 days from now is about 21.76 (This Kancera AB probability density function shows the probability of Kancera Stock to fall within a particular range of prices over 90 days) . Probability of Kancera AB price to stay between its current price of kr 0.97  and kr 2.07  at the end of the 90-day period is about 75.38 .
Assuming the 90 days trading horizon Kancera AB has a beta of -0.62. This indicates as returns on the benchmark increase, returns on holding Kancera AB are expected to decrease at a much lower rate. During a bear market, however, Kancera AB is likely to outperform the market. Additionally Kancera AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Kancera AB Price Density   
       Price  

Predictive Modules for Kancera AB

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kancera AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.051.039.10
Details
Intrinsic
Valuation
LowRealHigh
0.050.999.06
Details

Kancera AB Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Kancera AB is not an exception. The market had few large corrections towards the Kancera AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kancera AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kancera AB within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.88
β
Beta against Dow Jones-0.62
σ
Overall volatility
0.41
Ir
Information ratio -0.14

Kancera AB Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kancera AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kancera AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kancera AB generated a negative expected return over the last 90 days
Kancera AB has high historical volatility and very poor performance
Kancera AB has some characteristics of a very speculative penny stock
The company reported the revenue of 1.7 M. Net Loss for the year was (45.69 M) with profit before overhead, payroll, taxes, and interest of 1.7 M.
Kancera AB has accumulated about 106.52 M in cash with (44.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Roughly 14.0% of the company outstanding shares are owned by corporate insiders

Kancera AB Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kancera Stock often depends not only on the future outlook of the current and potential Kancera AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kancera AB's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding56.1 M
Cash And Short Term Investments106.5 M

Kancera AB Technical Analysis

Kancera AB's future price can be derived by breaking down and analyzing its technical indicators over time. Kancera Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kancera AB. In general, you should focus on analyzing Kancera Stock price patterns and their correlations with different microeconomic environments and drivers.

Kancera AB Predictive Forecast Models

Kancera AB's time-series forecasting models is one of many Kancera AB's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kancera AB's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Kancera AB

Checking the ongoing alerts about Kancera AB for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kancera AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kancera AB generated a negative expected return over the last 90 days
Kancera AB has high historical volatility and very poor performance
Kancera AB has some characteristics of a very speculative penny stock
The company reported the revenue of 1.7 M. Net Loss for the year was (45.69 M) with profit before overhead, payroll, taxes, and interest of 1.7 M.
Kancera AB has accumulated about 106.52 M in cash with (44.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Roughly 14.0% of the company outstanding shares are owned by corporate insiders

Additional Tools for Kancera Stock Analysis

When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.